Animal models of Wilson disease

Area of Science:

• Genetics
• Toxicology
• Animal Models

Background:

• Wilson disease (WD) stems from ATP7B gene mutations, leading to copper toxicity in the liver and brain.
• Despite identifying the gene in 1993, WD's copper toxicity mechanisms and diverse phenotypes remain unclear.
• ATP7B homolog defects in animal models provide valuable insights into WD pathomechanisms.

Purpose of the Study:

• To review the utility of existing animal models for studying Wilson disease.
• To highlight how these models contribute to understanding copper metabolism and WD pathology.
• To emphasize the role of animal models in developing therapeutic strategies for WD.

Main Methods:

• Review of four rodent models (LEC rat, tx/tx-j mice, ATP7B knockout mice) with ATP7B gene defects.
• Examination of copper accumulation and neurological involvement in these models.
• Comparison of canine models with human WD, noting genetic differences.

Main Results:

• Rodent models exhibit varying degrees of liver disease due to ATP7B defects.
• LEC rats and tx/tx-j mice show brain copper accumulation and mild neurological signs, less severe than human WD.
• Canine models display hepatic copper toxicity but lack observed brain involvement and have different genetic defects.

Conclusions:

• Animal models are crucial for studying copper distribution, metabolism, and WD-related pathology.
• These models are essential for evaluating potential therapeutic interventions like drug, gene, and cell therapies.
• Research using animal models is key to advancing the development of effective WD treatments.